Friday, October 30, 2026

BTC $76,901 ▼ 1.16%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.192+0.94%ETH$2,217−1.42%LINK$11.03+4.02%SOL$95.36−0.03%BTC$76,901−1.16%XRP$1.24+0.48%S&P 5007,617−1.34%Nasdaq25,526−2.52%Dow52,134−0.40%RUT2,859+1.01%TNX4.93%−1.24%TYX5.29%−0.68%FVX4.73%−1.48%IRX3.98%−0.40%VIX18.68+8.60%GOLD$3,956.00−1.87%SILVER$49.85−4.84%OIL$103.95+1.91%DXY101.91−0.13%NVDA$205.98−3.59%AAPL$345.64−0.94%TSLA$387.89−3.82%META$611.14−2.14%MSFT$516.43−2.59%AMZN$233.13−4.37%GOOGL$281.20−0.92%Fear & Greed30 — FearADA$0.192+0.94%ETH$2,217−1.42%LINK$11.03+4.02%SOL$95.36−0.03%BTC$76,901−1.16%XRP$1.24+0.48%S&P 5007,617−1.34%Nasdaq25,526−2.52%Dow52,134−0.40%RUT2,859+1.01%TNX4.93%−1.24%TYX5.29%−0.68%FVX4.73%−1.48%IRX3.98%−0.40%VIX18.68+8.60%GOLD$3,956.00−1.87%SILVER$49.85−4.84%OIL$103.95+1.91%DXY101.91−0.13%NVDA$205.98−3.59%AAPL$345.64−0.94%TSLA$387.89−3.82%META$611.14−2.14%MSFT$516.43−2.59%AMZN$233.13−4.37%GOOGL$281.20−0.92%Fear & Greed30 — Fear

Tag

AbbVie

3 articles

U.S. Equities1h ago

AbbVie Raises FY Guidance on Skyrizi, Rinvoq Momentum

AbbVie beat Q3 EPS and revenue estimates, raising full-year adjusted EPS guidance to $13.95-$13.99 on strength in immunology franchises

U.S. Equities27d ago

AbbVie's Juvmo Approval Validates $8.7B Cerevel Bet, Eyes $1.4B Peak Sales

FDA approval of Juvmo, AbbVie's once-daily Parkinson's treatment, delivers near-term validation of its Cerevel acquisition and positions a new growth driver as Humira patent cliff deepens.

U.S. Equities175d ago

AbbVie's Aesthetics Unit Gains From Korea's Cosmetic Surgery Boom

South Korea's expanding cosmetic surgery market signals strong growth for U.S. medical aesthetics companies like AbbVie